<unk>  is an aromatase Inhibitor that is FDA approved for the treatment of advanced breast cancer in postmenopausal women and adjuvant treatment of postmenopausal women.   Common adverse reactions include hot flushes, fatigue, arthralgia, headache, insomnia, and increased sweating, nausea, fatigue and increased appetite.
Exemestane
Anastrozole
Fosfestrol
Tamoxifen
Formestane
Goserelin
Gestodene
Buserelin